Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 417

    Roche CEO still optimistic on new breast cancer drug

    Roche CEO still optimistic on new breast cancer drug

    Ruby Khatun Khatun12 Jun 2017 11:21 AM IST
    VIENNA: Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that...
    Teva Pharma looks to refresh board with four new nominees

    Teva Pharma looks to refresh board with four new nominees

    Ruby Khatun Khatun12 Jun 2017 9:17 AM IST
    JERUSALEM: Israel's Teva Pharmaceutical Industries is looking to refresh its board of directors with four new members as it tries to restore investor...
    Biocon Appoints Pratima Rao as Mission Director of Biocon Foundation

    Biocon Appoints Pratima Rao as Mission Director of Biocon Foundation

    Ruby Khatun Khatun11 Jun 2017 11:57 AM IST
    Bengaluru: Biocon Ltd, Asia's premier biopharmaceuticals company, announced that Ms. Pratima Rao has been appointed as Mission Director & Head of...
    AbbVie must pay 15 million dollar in Depakote birth-defect trial: jury

    AbbVie must pay 15 million dollar in Depakote birth-defect trial: jury

    Ruby Khatun Khatun11 Jun 2017 11:57 AM IST
    A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc's bipolar disorder drug Depakote...
    AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig

    AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig

    Ruby Khatun Khatun11 Jun 2017 11:56 AM IST
    AstraZeneca announced that it has entered an agreement with Grünenthal for the global rights to Zomig (zolmitriptan) outside Japan. Zomig is indicated...
    Top EU court bars Dextro Energy on glucose health claims

    Top EU court bars Dextro Energy on glucose health claims

    Ruby Khatun Khatun11 Jun 2017 9:08 AM IST
    BRUSSELS: The European Union's top court barred Germany's Dextro Energy on Thursday from making claims about the health benefits of glucose contained...
    OPPI hosts Sixth Healthcare Access Summit for NCD Management

    OPPI hosts Sixth Healthcare Access Summit for NCD Management

    Ruby Khatun Khatun10 Jun 2017 1:02 PM IST
    New Delhi: The Organisation of Pharmaceutical Producers of India (OPPI) hosted its Sixth Healthcare Access Summit, supported by the Ministry of Health...
    Deutsche Bank hires Nick Richitt as Managing Director in Healthcare Investment Banking

    Deutsche Bank hires Nick Richitt as Managing Director in Healthcare Investment Banking

    Ruby Khatun Khatun10 Jun 2017 12:59 PM IST
    NEW YORK: Deutsche Bank announced it has hired Nick Richitt as a Managing Director in Healthcare Investment Banking focusing on Healthcare IT and...
    Mylan to Present at Goldman Sachs 38th Annual Global Healthcare Conference

    Mylan to Present at Goldman Sachs 38th Annual Global Healthcare Conference

    Ruby Khatun Khatun10 Jun 2017 11:54 AM IST
    Mylan N.V. a leading global pharmaceutical company, announced that the Company will present at the Goldman Sachs 38th Annual Global Healthcare...
    FDA asks drug maker Endo Pharmaceuticals to withdraw opioid for risks related to abuse

    FDA asks drug maker Endo Pharmaceuticals to withdraw opioid for risks related to abuse

    Ruby Khatun Khatun10 Jun 2017 10:56 AM IST
    The U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone...
    Actelion antibiotic misses mark on one study, hits it on another

    Actelion antibiotic misses mark on one study, hits it on another

    Ruby Khatun Khatun10 Jun 2017 10:54 AM IST
    Swiss biotechnology company Actelion on Thursday presented mixed trial results for its antibiotic hopeful cadazolid, saying it met the main goal of...
    Vivimed Labs soars on Nil observation from USFDA

    Vivimed Labs soars on Nil observation from USFDA

    Ruby Khatun Khatun9 Jun 2017 11:29 AM IST
    Vivimed Labs gained as USFDA has given zero 483 observations after inspecting the company's API manufacturing facility in Sant Celoni, Spain.The...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok